The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, ...
The beauty conglomerate has joined with biotechnology and pharmaceutical company Serpin Pharma for ingredient research.
Estee Lauder (EL) announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory ...
The move forms part of ELC’s newly unveiled Beauty Reimagined strategic vision, which aims to help the company return to ...
The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory research can be ...
NEW YORK — The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory research can be ...
The beauty industry continues to outperform market expectations by leveraging innovative product lines and digital strategies ...
Pykus Therapeutics, Inc. ("Pykus" or the "Company"), a medical technology company dedicated to improving the lives of patients with blinding eye diseases, today announced it has secured a new patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results